SubjectWell Acquires PatientCentra to Expand Global Patient Recruitment Capabilities
SubjectWell, the patient access marketplace connecting individuals with chronic health conditions to new care options, has announced its acquisition of PatientCentra, a business under MD Connect, Inc. With this acquisition, SubjectWell gains full-service global patient recruitment capabilities and an in-house agency specializing in tailored, patient-centric recruitment journeys. The acquisition enables SubjectWell to address the patient recruitment needs of international clinical studies while expanding its ability to recruit for rare disease and oncology indications.
Meeting Global Customer Demands
SubjectWell's CEO, Fred Martin, states that the acquisition was driven by the demand from their global customer base for recruitment support on large, multi-country trials. With PatientCentra's 15 years of experience in delivering digitally enabled patient recruitment programs across five continents, SubjectWell can now provide unparalleled support for life-improving research on a global scale.
Enhanced Clinical Recruitment Solutions
The founder and CEO of PatientCentra, Dan Stempel, expresses pride in joining SubjectWell and highlights the opportunity to offer their customized clinical recruitment solutions to SubjectWell's customer base. This includes multi-channel outreach, patient websites, and concierge support. The combined expertise of both companies will enable end-to-end, global patient recruitment support for studies focused on vaccines, chronic conditions, rare diseases, and oncology.
In conclusion, SubjectWell's acquisition of PatientCentra strengthens its position as a leader in patient recruitment for clinical trials. The expanded capabilities and global reach will benefit researchers, sponsors, and patients alike, facilitating the advancement of medical research and the development of innovative treatments.
The Impact of SubjectWell's Acquisition of PatientCentra on New Businesses
SubjectWell's acquisition of PatientCentra is a game-changer in the realm of patient recruitment for clinical trials. This move not only expands SubjectWell's reach but also enhances its services, making it a formidable player in the industry. For new businesses in the health sector, this development could signal a shift in the landscape of patient recruitment. With SubjectWell now offering full-service global patient recruitment capabilities, the bar has been raised. New businesses will need to match, if not exceed, these enhanced services to stay competitive.
Moreover, the acquisition reflects the growing demand for comprehensive, multi-country trials. This global approach to patient recruitment could become the new norm, pushing new businesses to think beyond local or national boundaries. The emphasis on patient-centric recruitment journeys also highlights the importance of personalizing patient experiences, a trend that new businesses will need to incorporate into their strategies.
The merger of SubjectWell and PatientCentra creates a powerhouse that can support a wide range of studies, from vaccines to rare diseases. For new businesses, this could mean a need to diversify their focus and expand their expertise. In conclusion, SubjectWell's acquisition of PatientCentra is a wake-up call for new businesses to step up their game in patient recruitment.
.svg)
